Personalized cancer avatars for patients with thymic malignancies: A pilot study with circulating tu...
Personalized cancer avatars for patients with thymic malignancies: A pilot study with circulating tumor cell-derived organoids
About this item
Full title
Author / Creator
Publisher
Singapore: John Wiley & Sons, Inc
Journal title
Language
English
Formats
Publication information
Publisher
Singapore: John Wiley & Sons, Inc
Subjects
More information
Scope and Contents
Contents
Systemic therapy is the primary treatment for advanced thymic malignancies. However, there is an urgent need to improve clinical outcome. Personalized treatment based on predictive biomarkers is a potential approach to address this requirement. In this study, we aimed to show the correlation between drug sensitivity tests on CTCs-derived organoids...
Alternative Titles
Full title
Personalized cancer avatars for patients with thymic malignancies: A pilot study with circulating tumor cell-derived organoids
Authors, Artists and Contributors
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_doaj_primary_oai_doaj_org_article_5371253bf06e44099b9f64200c02042b
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_5371253bf06e44099b9f64200c02042b
Other Identifiers
ISSN
1759-7706
E-ISSN
1759-7714
DOI
10.1111/1759-7714.15039
